{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:30:31Z","timestamp":1780601431080,"version":"3.54.1"},"reference-count":43,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Severe, acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a rapid deterioration of the respiratory symptoms of patients with COPD, requiring hospital admission and escalation of pharmacological and nonpharmacological care including the more severe cases of respiratory failure and admission to an intensive care unit (ICU). These events severely impact patients' quality of life and prognosis. This review will describe the nonantibiotic, pharmacological treatment options available for critically ill patients with AECOPD. The aim of treatment is to alleviate symptoms, improve patient's functional and respiratory status, reduce mortality, reduce the risk or the duration of invasive mechanical ventilation, and prevent reexacerbations. Inhaled bronchodilators (i.e., short-acting \u03b22-agonists and anticholinergics) and systemic corticosteroids are the main drugs used in the treatment of AECOPD. These drugs are also used in the treatment of stable COPD and in the treatment of AECOPD patients in the non-ICU or community setting. Other drugs are essentially only used in the ICU setting such as inhaled anesthetic agents, ketamine, intravenous methylxanthines, and magnesium. Finally, recently developed drugs, such as the specific phosphodiesterase-4 inhibitors, may play a role in the prevention of relapsing AECOPD following a critical event than the treatment of the exacerbation itself. Although they significantly improve the survival of critically ill patients with AECOPD, none of available drugs, alone or combined, is able to significantly modify the prognosis of patients with COPD. This remains an open challenge for the current and future generations of researchers and clinicians.<\/jats:p>","DOI":"10.1055\/s-0040-1714379","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T22:54:00Z","timestamp":1596063240000},"page":"842-850","source":"Crossref","is-referenced-by-count":7,"title":["Nonantibiotic Pharmacological Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations"],"prefix":"10.1055","volume":"41","author":[{"given":"Francesco","family":"Vasques","sequence":"additional","affiliation":[{"name":"Department of Adult Critical Care, Guy's and St. Thomas' NHS Foundation Trust, King\u2019s Health Partners, London, United Kingdom"},{"name":"Division of Centre of Human Applied Physiological Sciences, King's College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Camporota","sequence":"additional","affiliation":[{"name":"Department of Adult Critical Care, Guy's and St. Thomas' NHS Foundation Trust, King\u2019s Health Partners, London, United Kingdom"},{"name":"Division of Centre of Human Applied Physiological Sciences, King's College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Barrett","sequence":"additional","affiliation":[{"name":"Department of Adult Critical Care, Guy's and St. Thomas' NHS Foundation Trust, King\u2019s Health Partners, London, United Kingdom"},{"name":"Division of Centre of Human Applied Physiological Sciences, King's College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/resp.12660","article-title":"Global burden of COPD","volume":"21","author":"J L L\u00f3pez-Campos","year":"2016","journal-title":"Respirology"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S2213-2600(15)00157-5","article-title":"Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data","volume":"3","author":"J B Soriano","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"J J Soler-Catalu\u00f1a","year":"2005","journal-title":"Thorax"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/archinte.163.10.1180","article-title":"In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease","volume":"163","author":"S P Patil","year":"2003","journal-title":"Arch Intern Med"},{"issue":"06","key":"ref6","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1378\/chest.12-2204","article-title":"Hospitalization due to COPD exacerbation","volume":"142","author":"L J Nannini","year":"2012","journal-title":"Chest"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"J R Hurst","year":"2010","journal-title":"N Engl J Med"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1183\/09031936.00043710","article-title":"Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach","volume":"37","author":"M Hoogendoorn","year":"2011","journal-title":"Eur Respir J"},{"issue":"02","key":"ref10","first-page":"CD002984","article-title":"Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease","author":"D C McCrory","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13643-018-0860-0","article-title":"Short-acting bronchodilators for the management of acute exacerbations of chronic obstructive pulmonary disease in the hospital setting: systematic review","volume":"7","author":"Z A Kopsaftis","year":"2018","journal-title":"Syst Rev"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2146\/ajhp160979","article-title":"Treatment patterns for patients hospitalized with chronic obstructive pulmonary disease","volume":"75","author":"A N Amin","year":"2018","journal-title":"Am J Health Syst Pharm"},{"issue":"08","key":"ref13","first-page":"CD011826","article-title":"Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD","author":"W H van Geffen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12890-018-0720-7","article-title":"Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial","volume":"18","author":"G Bardsley","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"S 01","key":"ref15","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2016-209729","article-title":"BTS guideline for oxygen use in adults in healthcare and emergency settings","volume":"72","author":"B R O'Driscoll","year":"2017","journal-title":"Thorax"},{"issue":"08","key":"ref16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1056\/NEJM198808253190806","article-title":"Ipratropium bromide","volume":"319","author":"N J Gross","year":"1988","journal-title":"N Engl J Med"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000029295","article-title":"Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease","volume":"65","author":"N Gross","year":"1998","journal-title":"Respiration"},{"issue":"05","key":"ref18","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1378\/chest.105.5.1411","article-title":"In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial","volume":"105","author":"COMBIVENT Inhalation Aerosol Study Group","year":"1994","journal-title":"Chest"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0196-0644(95)70260-1","article-title":"Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of chronic obstructive pulmonary disease","volume":"25","author":"R K Cydulka","year":"1995","journal-title":"Ann Emerg Med"},{"issue":"07","key":"ref21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.rmed.2008.02.010","article-title":"Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease","volume":"102","author":"S P Bhatt","year":"2008","journal-title":"Respir Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"329476","DOI":"10.1155\/2014\/329476","article-title":"Association of serum magnesium levels with frequency of acute exacerbations in chronic obstructive pulmonary disease: a prospective study","volume":"2014","author":"A Gumus","year":"2014","journal-title":"Pulm Med"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/1817-1737.128844","article-title":"Magnesium for acute exacerbation of chronic obstructive pulmonary disease: a systematic review of randomised trials","volume":"9","author":"M C Shivanthan","year":"2014","journal-title":"Ann Thorac Med"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/thoraxjnl-2012-202225","article-title":"Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial","volume":"68","author":"L Edwards","year":"2013","journal-title":"Thorax"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.327.7416.643","article-title":"Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials","volume":"327","author":"R G Barr","year":"2003","journal-title":"BMJ"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"1700158","DOI":"10.1183\/13993003.00158-2017","article-title":"Effect of roflumilast in patients with severe COPD and a history of hospitalisation","volume":"50","author":"K F Rabe","year":"2017","journal-title":"Eur Respir J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(14)62410-7","article-title":"Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial","volume":"385","author":"F J Martinez","year":"2015","journal-title":"Lancet"},{"issue":"03","key":"ref28","doi-asserted-by":"crossref","first-page":"1600791","DOI":"10.1183\/13993003.00791-2016","article-title":"Management of COPD exacerbations: a European Respiratory Society\/American Thoracic Society guideline","volume":"49","author":"J AEC-C Wedzicha","year":"2017","journal-title":"Eur Respir J"},{"issue":"08","key":"ref29","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/thoraxjnl-2015-207962","article-title":"Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial","volume":"71","author":"J F Fraser","year":"2016","journal-title":"Thorax"},{"issue":"09","key":"ref30","first-page":"CD001288","article-title":"Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease","author":"J A Walters","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(98)11326-0","article-title":"Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial","volume":"354","author":"L Davies","year":"1999","journal-title":"Lancet"},{"issue":"25","key":"ref32","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199906243402502","article-title":"Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease","volume":"340","author":"D E Niewoehner","year":"1999","journal-title":"N Engl J Med"},{"issue":"21","key":"ref33","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/archinternmed.2011.530","article-title":"Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support","volume":"171","author":"I Al\u00eda","year":"2011","journal-title":"Arch Intern Med"},{"issue":"03","key":"ref34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1183\/09031936.00002913","article-title":"Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation","volume":"43","author":"F Abroug","year":"2014","journal-title":"Eur Respir J"},{"issue":"06","key":"ref35","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1378\/chest.07-0208","article-title":"Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study","volume":"132","author":"Y P de Jong","year":"2007","journal-title":"Chest"},{"issue":"09","key":"ref36","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1164\/rccm.201401-0058OC","article-title":"Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease","volume":"189","author":"T H Kiser","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"21","key":"ref37","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2013.5023","article-title":"Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial","volume":"309","author":"J D Leuppi","year":"2013","journal-title":"JAMA"},{"key":"ref38","first-page":"CD006897","article-title":"Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease","volume":"3","author":"J A Walters","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1378\/chest.119.3.726","article-title":"Systemic glucocorticoids in severe exacerbations of COPD","volume":"119","author":"A Sayiner","year":"2001","journal-title":"Chest"},{"issue":"02","key":"ref40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1213\/01.ANE.0000140240.83236.AC","article-title":"The effect of volatile anesthetics on respiratory system resistance in patients with chronic obstructive pulmonary disease","volume":"100","author":"C A Volta","year":"2005","journal-title":"Anesth Analg"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1183\/09031936.98.12061242","article-title":"Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression","volume":"12","author":"E R Swenson","year":"1998","journal-title":"Eur Respir J"},{"issue":"03","key":"ref42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00134-015-3649-9","article-title":"Increased serum bicarbonate in critically ill patients: a retrospective analysis","volume":"41","author":"A B Lib\u00f3rio","year":"2015","journal-title":"Intensive Care Med"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jama.2016.0019","article-title":"Effect of acetazolamide vs placebo on duration of invasive mechanical ventilation among patients with chronic obstructive pulmonary disease: a randomized clinical trial","volume":"315","author":"C Faisy","year":"2016","journal-title":"JAMA"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2229-5151.152296","article-title":"Impact of acetazolamide use in severe exacerbation of chronic obstructive pulmonary disease requiring invasive mechanical ventilation","volume":"5","author":"M Bahloul","year":"2015","journal-title":"Int J Crit Illn Inj Sci"},{"issue":"07","key":"ref45","first-page":"1086","article-title":"Acetazolamide use in severe chronic obstructive pulmonary disease. pros and cons","volume":"14","author":"R Adamson","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2466-4-13","article-title":"Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]","volume":"4","author":"P N Black","year":"2004","journal-title":"BMC Pulm Med"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0040-1714379.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T23:34:48Z","timestamp":1605137688000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0040-1714379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":43,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2020,11,11]]},"published-print":{"date-parts":[[2020,12]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0040-1714379","relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]}}}